LLY

754.57

-0.24%↓

JNJ

178.08

-0.17%↓

ABBV

218.3

-0.8%↓

UNH

352.9

-0.29%↓

AZN

79.54

-1.96%↓

LLY

754.57

-0.24%↓

JNJ

178.08

-0.17%↓

ABBV

218.3

-0.8%↓

UNH

352.9

-0.29%↓

AZN

79.54

-1.96%↓

LLY

754.57

-0.24%↓

JNJ

178.08

-0.17%↓

ABBV

218.3

-0.8%↓

UNH

352.9

-0.29%↓

AZN

79.54

-1.96%↓

LLY

754.57

-0.24%↓

JNJ

178.08

-0.17%↓

ABBV

218.3

-0.8%↓

UNH

352.9

-0.29%↓

AZN

79.54

-1.96%↓

LLY

754.57

-0.24%↓

JNJ

178.08

-0.17%↓

ABBV

218.3

-0.8%↓

UNH

352.9

-0.29%↓

AZN

79.54

-1.96%↓

Search

Glaukos Corp

Chiusa

SettoreSettore sanitario

82.73 -5.43

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

82.5

Massimo

84.22

Metriche Chiave

By Trading Economics

Entrata

-1.5M

-20M

Vendite

17M

124M

Margine di Profitto

-15.837

Dipendenti

995

EBITDA

12M

-8.6M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+46.98% upside

Dividendi

By Dow Jones

Utili prossimi

3 nov 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-154M

5.3B

Apertura precedente

88.16

Chiusura precedente

82.73

Notizie sul Sentiment di mercato

By Acuity

50%

50%

175 / 371 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Very Strong Bearish Evidence

Glaukos Corp Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

12 set 2025, 22:41 UTC

I principali Market Mover

GlucoTrack Stock Falls on Plans to Sell $3 Million Note

12 set 2025, 16:04 UTC

I principali Market Mover

Upexi Shares Climb on Solana Gains

12 set 2025, 15:03 UTC

I principali Market Mover

Allied Gaming & Entertainment Shares Surge Following Crypto Investments

12 set 2025, 20:50 UTC

Discorsi di Mercato
Utili

Tech, Media & Telecom Roundup: Market Talk

12 set 2025, 20:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

12 set 2025, 20:09 UTC

Utili

Correction to Opendoor Is Sliding. Don't Call It a Meme Stock, Says New Chairman. -- Barrons.com

12 set 2025, 19:23 UTC

Discorsi di Mercato

Oil Futures End Volatile Week With Moderate Gains -- Market Talk

12 set 2025, 19:16 UTC

Discorsi di Mercato

Oil Futures End Volatile Week With Moderate Gains -- Market Talk

12 set 2025, 19:03 UTC

Discorsi di Mercato

Natural Gas Futures Held Back By Plump Inventories -- Market Talk

12 set 2025, 18:59 UTC

Discorsi di Mercato

Dollar Pares Gains as Economy Keeps Showing Signs of Cooling -- Market Talk

12 set 2025, 18:38 UTC

Discorsi di Mercato
Utili

Adobe Seen Reaching Turning Point in AI Cycle -- Market Talk

12 set 2025, 18:33 UTC

Discorsi di Mercato

U.S. Oil Rig Count Rises By 2 to 416 -- Market Talk

12 set 2025, 18:22 UTC

Discorsi di Mercato

Canada's Divergence With US On Capex Spending is 'Appalling' -- Market Talk

12 set 2025, 16:56 UTC

Discorsi di Mercato

Renewable Fuels Association Calls for Nationwide E15 Following WASDE -- Market Talk

12 set 2025, 16:22 UTC

Utili

Adobe Earnings Were 'Solid.' Long-Term Growth Concerns Remain. -- Barrons.com

12 set 2025, 16:20 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

12 set 2025, 16:19 UTC

Acquisizioni, Fusioni, Takeovers

These Stocks Are Moving the Most Today: Warner Bros., Paramount Skydance, Tesla, Super Micro, Microsoft, Figure Technology, and More -- Barrons.com

12 set 2025, 16:15 UTC

Discorsi di Mercato

Global Commodities Roundup: Market Talk

12 set 2025, 16:11 UTC

Utili

Novartis Catches a 'Sell.' Goldman Sachs Says the Stock Is Overvalued. -- Barrons.com

12 set 2025, 15:37 UTC

Discorsi di Mercato

Gold Holds Near All-Time Highs Ahead of Fed Meeting Next Week -- Market Talk

12 set 2025, 15:22 UTC

Discorsi di Mercato

European Gas Lifted by Geopolitical Risks But Storage Levels Ease Supply Fears -- Market Talk

12 set 2025, 15:07 UTC

Acquisizioni, Fusioni, Takeovers

These Stocks Are Moving the Most Today: Warner Bros., Paramount Skydance, Tesla, Super Micro, Microsoft, Figure Technology, and More -- Barrons.com

12 set 2025, 14:34 UTC

Discorsi di Mercato

Russia Sanctions Put Bid Back in Oil -- Market Talk

12 set 2025, 14:10 UTC

Discorsi di Mercato

Inflation Report Unlikely to Dissuade Canada From Rate Cut -- Market Talk

12 set 2025, 13:58 UTC

Discorsi di Mercato

Dollar Could Rise if Fed Sounds Cautious on Rate Cuts -- Market Talk

12 set 2025, 13:58 UTC

Acquisizioni, Fusioni, Takeovers

These Stocks Are Moving the Most Today: Warner Bros., Paramount Skydance, Super Micro, Adobe, Microsoft, Figure Technology, and More -- Barrons.com

12 set 2025, 13:57 UTC

Utili

AbbVie Stock Hit a Record on 'Big Win' for Blockbuster Drug. The Case for Buying In. -- Barrons.com

12 set 2025, 13:56 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

12 set 2025, 13:56 UTC

Discorsi di Mercato

Canadian Dollar Faces Further Weakness Vs Non-U.S. Dollar Currencies -- Market Talk

12 set 2025, 13:54 UTC

Discorsi di Mercato

U.S. Natural Gas Recovers Ground -- Market Talk

Confronto tra pari

Modifica del prezzo

Glaukos Corp Previsione

Obiettivo di Prezzo

By TipRanks

46.98% in crescita

Previsioni per 12 mesi

Media 121.64 USD  46.98%

Alto 165 USD

Basso 92 USD

Basato su 12 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Glaukos Corp - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

12 ratings

10

Acquista

2

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

87.61 / 93Supporto e resistenza

A breve termine

Very Strong Bearish Evidence

A termine intermedio

Bearish Evidence

A lungo termine

Bearish Evidence

Sentiment

By Acuity

175 / 371 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Glaukos Corp

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.
help-icon Live chat